Trilogy Capital
LRCX icon

Trilogy Capital’s Lam Research LRCX Stock Holding History

Trilogy Capital’s Portfolio LRCX Stock Details LRCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-725
Closed -$314K – 421
2026
Q2 		$314K Buy
+725
New +$220K 0.01% 321

Other funds holding LRCX

Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Bank Julius Baer & Co
Bank Julius Baer & Co Zurich, Switzerland $39.3B AUM 31.81% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $57B AUM 43.56% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Trilogy Capital's LRCX Position: Q3 2026 in Review

Trilogy Capital sold out of Lam Research (LRCX) in Q3 2026, closing a stake of 725 shares — an estimated $314K sold.

Trilogy Capital first reported a position in LRCX in Q2 2026 and held it in 1 quarter. The position peaked at $314K in Q2 2026. 1,280 funds tracked by Wall St. Rank hold LRCX as of Q3 2026.

  • Trilogy Capital reported no remaining Lam Research position as of Q3 2026 after selling out during the quarter.
  • Trilogy Capital sold 725 Lam Research shares in Q3 2026, an estimated $314K.
  • Trilogy Capital first reported a position in Lam Research in Q2 2026 and held it in 1 quarter.
  • Trilogy Capital's Lam Research position peaked at $314K in Q2 2026.
  • 1,280 funds tracked by Wall St. Rank held Lam Research as of Q3 2026.

Based on Trilogy Capital's 13F filing for Q3 2026, filed 20 Oct 2026.